Physician

Manzoor Ahamed Bevinal, M.D.

According to 2025 Medicare claims, Manzoor Bevinal, M.D. (NPI: 1831326743) practices internal medicine in the Corpus Christi, TX market, with the plurality of this provider's patient population coming from Nueces, TX. This provider's primary affiliated billing organization is HHA HOSPITAL MEDICINE OF TEXAS PLLC (NPI: 1083489967; TIN: 93-4473770) and primary practice location at 78411-1820.

Bevinal's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 310 traditional Medicare patients, billed 1,303 HCPCS/CPT codes, and received $89,169 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 784 prescription claims across 206 beneficiaries totaling $25,021 in drug costs, led by Eliquis (Apixaban). DME data shows 64 claims. Open Payments data shows 1 records totaling $39. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $157,962 to $89,169. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $20,761 and ending at $25,021. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $7,205 and ending at $5,430.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	428	1,901	$157,962
2016	432	1,743	$143,769
2017	437	1,474	$183,565
2018	563	2,133	$178,406
2019	519	1,735	$152,600
2020	507	1,720	$151,978
2021	391	1,334	$111,688
2022	341	1,559	$116,876
2023	298	1,278	$100,383
2024	310	1,303	$89,169

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	105	331	$20,761
2016	104	256	$38,157
2017	105	230	$11,849
2018	182	404	$20,373
2019	184	393	$17,366
2020	187	409	$24,347
2021	168	396	$14,568
2022	218	652	$29,264
2023	250	911	$53,772
2024	206	784	$25,021

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	102	$6,243
2016	N/R	45	$1,896
2017	N/R	41	$1,588
2018	N/R	67	$1,777
2019	23	111	$4,634
2020	N/R	106	$5,674
2021	N/R	67	$3,989
2022	11	164	$9,896
2023	N/R	73	$4,397
2024	N/R	64	$4,960

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	237	265	$107
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	70	144	$77
99239	Hospital discharge day management, more than 30 minutes	71	73	$75
99238	Hospital discharge day management, 30 minutes or less	171	187	$55
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	190	614	$54

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	16	515	$10,066
Levetiracetam	Levetiracetam	17	404	$695
Famotidine	Famotidine	41	1,192	$294
Pantoprazole Sodium	Pantoprazole Sodium	29	1,110	$277
Gabapentin	Gabapentin	43	1,315	$272

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	39	$4,030
E1392	Portable oxygen concentrator, rental	Y	N/R	25	$930

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$39	Janssen Pharmaceuticals, Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Manzoor Ahamed Bevinal, M.D.?

Tedicare shows public-source Medicare data for Manzoor Ahamed Bevinal, M.D. (NPI 1831326743), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Manzoor Ahamed Bevinal, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Manzoor Ahamed Bevinal, M.D.?

Manzoor Ahamed Bevinal, M.D. is linked to HHA HOSPITAL MEDICINE OF TEXAS PLLC (billing NPI 1083489967) in the available physician profile data.

Does Manzoor Ahamed Bevinal, M.D. have Open Payments data?

Manzoor Ahamed Bevinal, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.